Can loss of agency and oppositional perturbation associated with antidepressant monotherapy and low-fidelity psychological treatment dilute the benefits of guideline-consistent depression treatment at the population level?

MLA

Ormel, Johan, et al. “Can Loss of Agency and Oppositional Perturbation Associated with Antidepressant Monotherapy and Low-Fidelity Psychological Treatment Dilute the Benefits of Guideline-Consistent Depression Treatment at the Population Level?” European Psychiatry : The Journal of the Association of European Psychiatrists, vol. 63, no. 1, Sept. 2020, p. e89. EBSCOhost, https://doi.org/10.1192/j.eurpsy.2020.86.

APA

Ormel, J., Bosker, F. J., Hollon, S. D., & Ruhe, H. G. (2020). Can loss of agency and oppositional perturbation associated with antidepressant monotherapy and low-fidelity psychological treatment dilute the benefits of guideline-consistent depression treatment at the population level? European Psychiatry : The Journal of the Association of European Psychiatrists, 63(1), e89. https://doi.org/10.1192/j.eurpsy.2020.86

Chicago

Ormel, Johan, Fokko J Bosker, Steven D Hollon, and Henricus G Ruhe. 2020. “Can Loss of Agency and Oppositional Perturbation Associated with Antidepressant Monotherapy and Low-Fidelity Psychological Treatment Dilute the Benefits of Guideline-Consistent Depression Treatment at the Population Level?” European Psychiatry : The Journal of the Association of European Psychiatrists 63 (1): e89. doi:10.1192/j.eurpsy.2020.86.